biotherapeut
includ
monoclon
antibodi
mab
fragment
import
segment
pharmaceut
industri
due
abil
bind
target
high
specif
affin
well
near
absenc
nonmechan
toxic
due
offtarget
bind
mabbas
drug
offer
attract
advantag
small
molecul
therapeut
hand
biotherapeut
drug
possess
complex
conform
heterogen
molecular
structur
vulner
chang
environ
complex
seri
process
step
product
administr
result
sever
physicochem
stress
molecul
stress
includ
high
concentr
variabl
temperatur
ph
extrem
vari
ionic
strength
shear
stress
airwat
well
varieti
solidliquid
interfac
result
potenc
puriti
final
drug
product
impact
via
multipl
degrad
pathway
henc
consider
interest
biopharmaceut
industri
toward
gain
fundament
understand
molecular
properti
determin
chemic
thermodynam
longterm
stabil
biotherapeut
molecul
aggreg
common
degrad
pathway
biotherapeut
besid
potenti
impact
drug
potenc
aggreg
also
consid
risk
factor
immunogen
particular
cross
biotherapeut
potenti
immunogen
henc
fundament
understand
molecul
prone
aggreg
other
would
go
long
way
toward
reduc
even
elimin
risk
factor
aggreg
also
topic
intens
research
protein
gener
accumul
experiment
evid
show
specif
region
protein
sequenc
especi
one
amyloidogen
properti
tend
drive
aggreg
earli
studi
small
protein
peptid
led
character
physicochem
properti
amyloid
amyloidlik
aggreg
associ
neurodegen
diseas
molecular
trigger
aggreg
gener
motif
whose
molecular
structur
recent
elucid
eisenberg
lab
format
motif
amyloidlik
aggreg
protein
quit
common
survey
literatur
found
experiment
evid
avail
seventi
differ
protein
show
aggreg
via
format
steric
zipper
motif
even
protein
bacteri
inclus
bodi
aggreg
via
rout
short
sequenc
region
potenti
drive
aggreg
detect
protein
call
aggreg
prone
region
apr
typic
apr
uniqu
featur
respect
charg
hydrophob
aromat
secondari
structur
prefer
number
comput
approach
develop
predict
potenti
apr
protein
predict
method
use
protein
sequenc
input
identifi
short
apr
residu
capabl
form
amyloidlik
fibril
method
base
pattern
recognit
threedimension
profil
molecular
simul
emerg
question
whether
also
apr
mab
led
hypothesi
noncoval
aggreg
biotherapeut
mani
parallel
seen
protein
gener
thioflavin
congo
red
marker
dye
commonli
use
detect
amyloidlik
aggreg
bind
steric
zipper
motif
aggreg
form
biopharmaceut
includ
therapeut
mab
toward
end
expir
date
report
bind
thioflavin
congo
red
recent
use
tango
page
identifi
potenti
apr
commerci
avail
therapeut
mab
therapeut
mab
studi
contain
sever
sequenc
region
strongli
predict
aggreg
prone
interest
find
studi
apr
locat
variabl
domain
primarili
complementaritydetermin
region
cdr
adjoin
framework
part
antibodi
molecul
also
contribut
significantli
toward
antigen
bind
henc
studi
indic
may
undesir
link
aggreg
tendenc
molecular
function
therapeut
mab
present
statist
survey
base
high
resolut
crystal
structur
fabantigen
complex
avail
protein
data
bank
also
includ
fabantigen
complex
commerci
avail
therapeut
mab
identifi
potenti
apr
fab
dataset
use
sequencebas
predict
tool
tango
page
solventaccess
surfac
area
buri
upon
fabantigen
complex
format
use
paramet
gaug
fabantigen
interact
contribut
potenti
apr
toward
antigen
recognit
literatur
proteinprotein
interact
commonli
measur
use
approach
reli
energet
contact
residu
buri
surfac
area
interfac
two
approach
close
relat
studi
prefer
use
buri
surfac
area
metric
easili
calcul
moreov
wide
use
studi
proteinprotein
interact
fab
dataset
contain
least
one
apr
one
fabantigen
complex
residu
cdrlocal
apr
also
contribut
toward
antigen
bind
henc
find
potenti
apr
may
contribut
significantli
toward
antigen
bind
aromat
residu
tyr
trp
occur
high
propens
apr
antigen
bind
site
incid
apr
uniform
cdr
loop
particular
apr
less
frequent
heavi
chain
cdr
loop
hand
apr
found
greatest
frequenc
heavi
chain
cdr
loop
ration
structurebas
design
strategi
therapeut
antibodi
candid
high
potenc
improv
druggabl
propos
term
antigen
use
throughout
refer
bind
partner
fab
complex
defin
janeway
et
al
complex
includ
studi
collect
protein
data
bank
base
follow
criteria
resolut
better
b
antigen
protein
least
residu
complex
small
molecul
hapten
polysaccharid
peptid
rna
antigen
includ
c
complex
full
fab
structur
complex
fv
singl
chain
antibodi
includ
antibodi
sequenc
contain
complex
nonredund
last
criterion
hard
meet
antibodi
sequenc
show
high
homolog
variabl
constant
region
includ
align
retain
one
complex
best
resolut
set
complex
light
chain
heavi
chain
fab
show
greater
sequenc
ident
choic
sequenc
ident
arbitrari
averag
sequenc
ident
variabl
region
fab
light
heavi
chain
final
dataset
respect
indic
fair
coverag
antibodi
sequenc
variat
dataset
one
complex
present
crystallograph
asymmetr
unit
one
copi
retain
e
catalyt
antibodi
includ
final
dataset
consist
fabantigen
complex
resolut
rang
supplement
dataset
five
avail
commerci
fabantigen
complex
among
five
commerci
fabantigen
complex
one
complex
pdb
id
eightresiduelong
peptid
antigen
antigen
four
complex
protein
complex
satisfi
select
criterion
antigen
type
size
resolut
resolut
structur
vari
overal
complex
studi
resolut
rang
dataset
compar
favor
crystal
structur
dataset
use
previou
studi
antibodyantigen
complex
andrew
martin
definit
complementaritydetermin
region
cdr
antibodi
follow
chose
definit
base
antibodyantigen
contact
analysi
share
similar
identif
recognit
site
kabat
number
scheme
adopt
potenti
aggreg
prone
region
apr
identifi
use
similar
approach
describ
previou
work
two
sequencebas
predict
tool
viz
tango
page
use
identifi
potenti
apr
aggreg
propens
page
convert
z
score
identifi
region
statist
high
aggreg
propens
z
score
residu
calcul
follow
minim
usepackag
amsmath
usepackag
wasysym
usepackag
amsfont
usepackag
amssymb
usepackag
amsbsi
usepackag
mathrsf
usepackag
upgreek
setlength
oddsidemargin
begin
document
zi
frac
ln
left
pii
right
overlin
ln
left
pi
right
stdleft
ln
left
pi
right
right
end
document
documentclass
minim
usepackag
amsmath
usepackag
wasysym
usepackag
amsfont
usepackag
amssymb
usepackag
amsbsi
usepackag
mathrsf
usepackag
upgreek
setlength
oddsidemargin
begin
document
overlin
ln
left
pi
right
end
document
averag
aggreg
propens
sequenc
std
standard
deviat
averag
aggreg
propens
identifi
region
sequenti
consecut
residu
aggreg
prone
apr
follow
criteria
satisfi
tango
score
five
consecut
residu
apr
assign
type
consid
strong
predict
ii
page
z
score
least
apr
assign
type
consid
strong
predict
iii
tango
score
page
z
score
apr
assign
type
consid
weak
predict
tango
report
yield
success
rate
peptid
tango
score
greater
use
stringent
cutoff
ensur
apr
type
strongli
predict
apr
type
also
strong
predict
z
correspond
statist
confid
level
apr
type
weak
predict
due
lower
cutoff
valu
exampl
fig
show
tango
page
profil
light
chain
fab
vegfblock
complex
pdb
id
type
apr
identifi
criteria
label
chain
three
type
apr
apr
type
frequent
dataset
apr
residu
type
type
deliber
use
two
comput
program
substanti
differ
algorithm
philosophi
ensur
identif
apr
dataset
influenc
peculiar
train
set
algorithm
use
develop
comput
program
note
apr
type
type
often
overlap
fab
sequenc
overlap
apr
merg
singl
apr
data
analysi
complex
structur
first
scan
miss
heavi
atom
residu
complex
without
miss
atom
residu
optim
via
energi
minim
step
skip
miss
atom
complex
sidechainheavi
atom
built
use
rotam
librari
moe
qualiti
sidechain
model
built
moe
rank
base
energi
rmsd
sidechain
torsion
angl
sidechain
model
first
rank
chosen
complex
miss
backbon
atom
residu
full
structur
built
via
homolog
model
chain
contain
miss
residu
target
built
origin
structur
target
use
primari
structur
templat
homolog
model
addit
structur
templat
chosen
share
high
overal
sequenc
ident
target
sequenc
contain
coordin
miss
residu
thu
addit
templat
appli
miss
residu
homolog
model
intermedi
model
gener
rank
gener
bornvolum
integr
gbvi
score
model
best
gbvi
score
chosen
optim
via
energi
minim
allatom
forc
field
use
energi
minim
complex
cutoff
switch
start
appli
van
der
waal
well
coulomb
interact
gener
bornimplicit
solvat
employ
interior
exterior
dielectr
valu
respect
energi
minim
perform
two
step
hydrogen
atom
posit
optim
heavi
atom
kept
harmon
tether
b
atom
energi
minim
gradient
fall
optim
structur
show
less
rmsd
respect
origin
structur
use
buri
surfac
area
identifi
fabantigen
recognit
site
gaug
fabantigen
interfac
buri
surfac
area
refer
surfac
area
fab
antigen
access
solvent
fab
antigen
separ
becom
inaccess
solvent
due
fabantigen
complex
format
solventaccess
surfac
area
asa
calcul
use
algorithm
lee
richard
implement
program
accelri
discoveri
studio
probe
water
solvent
radiu
total
buri
surfac
area
complex
simpli
obtain
sum
asa
valu
isol
compon
minu
complex
calcul
buri
surfac
area
equival
hierarch
way
order
obtain
follow
quantiti
residu
fabantigen
recognit
site
b
total
buri
surfac
area
complex
contribut
fab
antigen
compon
c
contribut
apr
fab
buri
surfac
area
polar
fraction
buri
surfac
area
hierarch
calcul
start
atom
level
first
buri
surfac
area
atom
obtain
differ
asa
atom
isol
compon
complex
second
buri
surfac
area
residu
calcul
sum
buri
surfac
area
atom
residu
bind
site
identifi
residu
level
residu
consid
fabantigen
recognitionbind
site
buri
surfac
area
cutoff
arbitrari
also
tri
lower
cutoff
valu
differ
minor
third
buri
surfac
area
fab
antigen
sum
bind
residu
fab
antigen
respect
similar
way
buri
surfac
area
apr
fab
sum
bind
residu
also
belong
apr
final
total
buri
surfac
area
complex
obtain
sum
buri
surfac
area
fab
antigen
polar
nonpolar
buri
surfac
area
sum
polar
nonpolar
atom
respect
calcul
carbon
atom
treat
nonpolar
oxygen
nitrogen
atom
consid
polar
sulfur
atom
consid
nonpolar
disulfid
bond
otherwis
treat
polar
also
tri
identifi
interfac
contact
residu
use
distanc
method
employ
tsai
et
al
residu
pair
consid
contact
fab
antigen
least
one
heavi
atom
pair
two
residu
within
cutoff
valu
obtain
almost
ident
set
bind
site
residu
program
moe
use
search
hydrogen
bond
ion
pair
contact
fab
antigen
criteria
hydrogen
bond
propos
refer
follow
ion
pair
contact
infer
pair
nitrogen
oxygen
atom
belong
opposit
charg
residu
within
cutoff
propens
p
bi
amino
acid
bind
residu
fab
calcul
use
equat
minim
usepackag
amsmath
usepackag
wasysym
usepackag
amsfont
usepackag
amssymb
usepackag
amsbsi
usepackag
mathrsf
usepackag
upgreek
setlength
oddsidemargin
begin
document
p
bi
frac
n
bi
ni
nb
n
end
document
minim
usepackag
amsmath
usepackag
wasysym
usepackag
amsfont
usepackag
amssymb
usepackag
amsbsi
usepackag
mathrsf
usepackag
upgreek
setlength
oddsidemargin
begin
document
nb
sumlimit
n
bi
quad
n
sumlimit
ni
end
document
n
bi
number
amino
acid
bind
site
fab
n
total
number
amino
acid
heavi
light
chain
fab
dataset
n
b
total
number
bind
residu
fab
n
total
number
amino
acid
heavi
light
chain
fab
propens
p
ai
amino
acid
occur
apr
fab
calcul
similar
way
use
equat
minim
usepackag
amsmath
usepackag
wasysym
usepackag
amsfont
usepackag
amssymb
usepackag
amsbsi
usepackag
mathrsf
usepackag
upgreek
setlength
oddsidemargin
begin
document
p
ai
frac
n
ai
ni
na
n
end
document
minim
usepackag
amsmath
usepackag
wasysym
usepackag
amsfont
usepackag
amssymb
usepackag
amsbsi
usepackag
mathrsf
usepackag
upgreek
setlength
oddsidemargin
begin
document
na
sumlimit
n
ai
end
document
n
ai
number
amino
acid
apr
fab
n
total
number
apr
residu
n
n
mean
eq
multipl
sequenc
align
light
chain
heavi
chain
fab
present
fig
b
respect
potenti
apr
obtain
tango
page
analysi
highlight
fig
facilit
direct
comparison
among
complex
apr
variabl
domain
vl
vh
primarili
locat
cdr
loop
adjoin
strand
apr
constant
domain
cl
ch
well
conserv
term
locat
composit
fab
complex
contain
apr
least
one
cdr
loop
observ
consist
previou
find
even
though
differ
criteria
use
see
materi
method
section
detail
studi
classifi
apr
type
consid
apr
type
strong
predict
type
apr
weak
predict
apr
found
cdr
adjoin
region
type
apr
ftlti
locat
light
chain
framework
region
fab
type
howev
apr
involv
antigen
bind
tabl
ii
column
list
buri
surfac
area
fab
antigen
total
buri
surfac
area
complex
sum
buri
surfac
area
two
compon
name
fab
antigen
total
buri
surfac
area
complex
rang
reflect
gener
natur
proteinprotein
interfac
contribut
fab
antigen
total
buri
surfac
area
close
halfandhalf
averag
total
buri
surfac
area
complex
dataset
exclud
therapeut
fabpeptid
complex
pdb
id
buri
surfac
area
exclud
complex
particularli
small
due
small
size
peptid
antigen
contribut
apr
toward
antigen
recognit
measur
contribut
surfac
area
fab
buri
upon
complex
format
amino
acid
residu
cdrlocal
apr
contribut
toward
antigen
bind
fabantigen
complex
dataset
percentag
contribut
shown
tabl
ii
column
averag
rang
buri
surfac
area
fab
attribut
apr
variat
larg
exampl
case
murin
antibodi
fabprotein
complex
pdb
id
variabl
domain
contain
one
apr
fall
loop
particip
antigen
bind
case
vefgblock
complex
pdb
id
contribut
apr
highest
apr
contribut
buri
surfac
area
fab
complex
among
commerci
antibodi
except
neutral
fabvegf
complex
pdb
id
apr
account
greater
buri
surfac
area
fab
fig
show
exampl
structur
igg
fabvon
willebrand
factor
complex
pdb
id
case
buri
surfac
area
fab
attribut
bind
residu
belong
apr
observ
indic
aggreg
may
coupl
antigen
bind
function
antibodi
polar
fraction
buri
surfac
area
fab
share
apr
toward
fraction
shown
fig
b
respect
polar
surfac
area
calcul
studi
consist
buri
surfac
area
neutral
polar
charg
atom
averag
fab
part
interfac
polar
valu
similar
earlier
averag
valu
antibodyantigen
interfac
electrostat
polar
interact
known
import
factor
determin
affin
specif
antibodyantigen
complex
apr
consid
fig
found
antigenbind
region
fab
averag
polar
fraction
buri
surfac
area
apr
rang
exclud
two
outlier
describ
valu
similar
fab
howev
variat
wider
case
murin
antibodi
fabprotein
complex
complex
polar
fraction
complex
avail
none
apr
contribut
buri
surfac
area
fab
willebrand
factor
complex
complex
buri
surfac
area
apr
come
one
bind
residu
hydrophil
lead
polar
fraction
four
five
commerci
fabantigen
complex
apr
show
greater
polar
fraction
tabl
iii
list
antigenbind
residu
fab
bind
residu
also
belong
apr
highlight
bold
tabl
iii
buri
surfac
area
contribut
bind
residu
unequ
bind
residu
primarili
locat
cdr
loop
framework
region
fr
light
chain
identifi
bind
site
residu
complex
immedi
preced
loop
technic
fall
howev
pool
residu
analysi
sever
residu
cdr
loop
particip
antigen
bind
tabl
iv
howev
nonbind
residu
may
help
cdr
loop
acquir
proper
backbon
conform
essenti
bind
fig
b
compar
propens
individu
amino
acid
occur
antigenbind
site
apr
dataset
residu
propens
valu
one
favor
propens
valu
one
disfavor
result
gener
agreement
previou
analysi
antibodyantigen
interfac
exampl
trp
tyr
arg
favor
antigenbind
site
analysi
fig
also
hotspot
residu
protein
interfac
apr
consid
propens
calcul
apr
present
overal
sequenc
fab
includ
variabl
contribut
toward
bind
constant
domain
noncontribut
one
fig
result
consist
previou
analys
apr
aromat
residu
tyr
trp
aliphat
residu
val
ile
leu
favor
apr
charg
residu
strictli
avoid
apr
taken
togeth
aromat
residu
tyr
trp
favor
antigenbind
site
apr
henc
residu
may
coupl
agent
aggreg
antigen
recognit
fig
show
contribut
cdr
loop
toward
buri
surfac
area
fab
complex
averag
valu
along
number
bind
residu
cdr
length
also
present
tabl
iv
buri
surfac
area
valu
similar
obtain
wilson
stanfield
averag
loop
contribut
toward
antigen
bind
tabl
iv
portion
residu
directli
contact
antigen
also
greatest
loop
averag
buri
surfac
area
contribut
loop
normal
number
bind
residu
loop
loop
greatest
contribut
per
residu
consist
variabl
plot
antibodi
sequenc
statist
studi
antigencontact
residu
shown
loop
import
antibodi
specif
averag
contribut
loop
almost
equal
loop
tabl
iv
loop
longest
among
cdr
loop
residu
contribut
residu
toward
antigen
bind
tabl
iv
averag
buri
surfac
area
contribut
loop
third
largest
taken
togeth
three
loop
name
contribut
approxim
twothird
rang
buri
surfac
area
fab
shortest
cdr
loop
also
contribut
least
tabl
iv
fact
loop
contribut
toward
buri
surfac
area
fab
seven
complex
dataset
fig
tabl
iii
overal
contribut
cdr
loop
heavi
chain
cdr
loop
toward
buri
surfac
area
fab
rang
approxim
complex
heavi
chain
cdr
loop
contribut
less
also
count
number
hydrogen
bond
ion
pair
fab
antigen
studi
specif
interact
fabantigen
interfac
tabl
iv
averag
trend
loop
make
greatest
number
hydrogen
bond
ion
pair
contact
antigen
fig
b
plot
frequenc
coincid
apr
bind
residu
cdr
loop
valu
estim
potenti
coupl
aggreg
antigen
recognit
cdr
loop
residu
apr
also
among
antigenbind
residu
cdr
loop
averag
frequenc
two
import
antigenbind
contributor
show
differ
aggreg
coupl
frequenc
loop
highest
apr
incid
loop
show
lowest
incid
coincid
apr
bind
residu
cdr
loop
similar
biopharmaceut
end
expir
date
report
form
aggreg
bind
thioflavin
congo
red
thioflavin
tbind
characterist
aggreg
contain
structur
previou
analysi
show
biopharmaceut
report
maa
et
al
contain
sever
tangopag
predict
apr
see
tabl
iii
refer
moreov
tangopag
predict
apr
coincid
experiment
proven
fibrilform
segment
insulin
similar
result
observ
us
upon
exposur
sever
differ
mab
thermal
stress
intern
effort
data
shown
sever
experiment
report
studi
aggreg
protein
document
sequenc
chang
variant
homologu
mutant
reduc
aggreg
propens
found
disruptmitig
apr
predict
tango
page
analys
particular
cite
three
exampl
good
agreement
experi
comput
predict
bovin
growth
hormon
amyloidogen
immunoglobulin
light
chain
human
mab
summar
find
detail
case
present
supplementari
materi
first
base
experiment
studi
lehrman
et
al
identifi
sequenc
region
bovin
growth
hormon
bgh
involv
aggreg
tango
page
analys
indic
presenc
apr
region
experiment
design
variant
human
growth
hormon
hgh
differ
sequenc
region
show
reduc
aggreg
propens
experi
lehrman
et
al
consist
observ
tangopag
spectra
indic
apr
region
hgh
second
baden
et
al
identifi
three
nonconserv
somat
mutat
restor
amyloidogen
immunoglobulin
light
chain
germlin
sequenc
tango
spectrum
indic
strong
apr
contain
tango
aggreg
score
page
spectrum
show
apr
contain
tango
page
find
apr
involv
residu
posit
correspond
tango
spectra
germlin
sequenc
mutant
reduc
aggreg
propens
indic
apr
substanti
weaken
germ
line
light
chain
due
somat
disrupt
posit
howev
apr
identifi
page
remain
unchang
third
mutat
domain
intact
mab
studi
chennamsetti
et
al
reduc
aggreg
propens
shown
turbid
hplc
assay
improv
stabil
dsc
experi
see
tabl
fig
ref
mutat
actual
disrupt
strong
apr
tango
aggreg
score
found
fc
region
igg
mab
apr
well
conserv
among
immunoglobulin
gs
document
earlier
three
case
tango
page
also
detect
addit
apr
common
protein
variant
indic
potenti
reduct
aggreg
propens
molecul
use
tangopag
predict
combin
molecular
model
help
identifi
positionsmut
reduc
aggreg
propens
biotherapeut
recent
observ
disrupt
tangopredict
strong
apr
region
mab
singl
point
mutat
reduc
aggreg
propens
improv
solubl
indic
biophys
experi
inhous
effort
data
shown
similar
small
protein
peptid
potenti
apr
antibodi
also
short
sequenc
region
henc
one
chang
sequenc
disrupt
cdrlocal
apr
may
significantli
reduc
aggreg
propens
mab
product
formul
develop
point
view
improv
mab
stabil
solubl
desir
may
help
improv
express
level
cell
line
facilit
high
concentr
dosag
form
increas
product
howev
developabilityrel
sequenc
mutat
advers
impact
potenc
therapeut
mab
regard
observ
incid
potenti
apr
cdr
loop
adjac
framework
signific
disrupt
apr
without
affect
therapeut
mab
potenc
could
difficult
timeconsum
without
ration
approach
structurebas
input
simultan
consid
issu
may
lead
druggabl
therapeut
candid
present
studi
offer
use
guidelin
drug
candid
design
select
earli
discoveri
formul
stage
aromat
residu
tyr
trp
favor
apr
cdr
fig
aromat
amino
acid
known
play
import
role
direct
molecular
recognit
mostli
abil
form
interact
tyr
also
frequent
use
high
affin
proteinprotein
interfac
design
bogan
et
al
report
hotspot
bind
energi
protein
interfac
rich
trp
tyr
henc
caution
use
consid
mutat
tyr
trp
residu
mab
cdr
allevi
aggreg
could
also
impact
mab
potenc
instead
mutat
sequenc
neighbor
disrupt
apr
amyloidogen
sequenc
pattern
may
appropri
disrupt
apr
perform
way
cdr
loop
conform
especi
conform
residu
contribut
substanti
antigen
recognit
disturb
molecular
model
crystal
structur
fabantigen
complex
alanin
scan
experi
may
help
identifi
bind
hotspot
residu
mutat
affect
residu
avoid
preserv
potenc
averag
cdr
loop
contribut
toward
antigen
recognit
loop
contain
fewer
apr
case
loop
differ
bind
site
residu
contribut
unequ
toward
antigen
recognit
still
risk
mutat
loop
could
also
impact
potenc
mab
candid
especi
true
earli
discoveri
stage
fabantigen
complex
crystal
structur
yet
avail
antigenbind
residu
well
identifi
project
timelin
tight
hand
loop
contribut
least
toward
antigen
bind
often
contain
apr
fig
mutat
aim
disrupt
apr
region
could
help
improv
mab
stabil
without
significantli
impact
potenc
apart
loop
loop
region
disrupt
potenti
apr
reduc
mab
aggreg
tendenc
impact
potenc
substanti
hydrophob
residu
especi
val
ile
leu
high
propens
aggreg
antigen
bind
fig
henc
apr
disrupt
via
mutat
residu
polar
charg
residu
consid
especi
residu
close
cdr
region
surfac
expos
apr
disrupt
constant
region
mab
also
reduc
aggreg
propens
howev
case
therapeut
mab
caution
advis
potenti
drift
germlin
sequenc
